medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Number 618

<< Back Next >>

Rev Med Cos Cen 2016; 73 (618)

Coriorretinopatía central serosa

Abarca A

Language: Spanish
References: 12
Page: 113-117
PDF size: 163.42 Kb.


ABSTRACT

Central Serous Chorioretinopathy (CSCR) is a multifactorial disease, not clearly understood, of middleage patients, characterized by the collection of fluid between the retinal pigment epithelium (RPE) and the neurosensory retina. The exact etiology and the reason of its predominance in middle-age males are still unknown. Many pharmacologic modalities are proposed for the treatment of CSCR, now days it seems reasonable to suggest laser or photodynamic therapy.


REFERENCES

  1. Bousquet, E., Beydoun, T., Rothschild, P., Bergin, C., Zhao, M., Batista, R., et al. (2015). Spironolactone for Nonresolving Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases , 1-11.

  2. Hata, M., Oishi, A., Shimozono, M., Mandai, M., Nishida, A., & Kurimoto, Y. (2013). Early Changes in Foveal Thickness in Eyes with Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases , 296-301.

  3. Kim, D., Joe, S., Yang, H., Lee, J., Kim, J., & Yoon, Y. (2014). Subfoveal Choroidal Tickness Changes in Treated Idiopathic Central Serous Chorioretinopathy and their Association with Recurrence . Journal of Retineal and Vitreous Diseases, 1867-1874.

  4. Liu, D., Fok, A., & Lam, D. (2012). An Update on the Diagnosis and Management of Central Serous Chorioretinopathy. Asia-Pacific Journal of Ophtalmology , 296-302.

  5. Malik, K., Sampat, K., Mansouri, A., Steiner, J., & Glaser, B. (2015). Low- Intensity/High Density Subthreshold Micropulse Diode Laser for Chronic Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases, 532-536.

  6. 6-Peiretti, E., Ferrara, D., Caminiti, G., Mura, M., & Hughes, J. (2015). Choroidal Neovascularization in Caucasian Patients with Longstanding Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 1360-1367.

  7. Prakash, G., Chauhan, N., Jain, S., & Satsangi, K. (2013). Central Serous Chorioretinopathy: a Review of Literature. Asia-Pacific Journal of Ophthalmology , 104-110.

  8. Ross, A., Ross, A., & Mohamed, Q. (2011). Review and Update of Central Serous Chorioretinopathy. Current Opinion in Ophthalmology, 166-173.

  9. Shiode, Y., Morizane, Y., Kimura, S., Hosokawa, M., Kawata, T., Doi, S., et al. (2015). Comparison of Halving the Irradiation Time or the Verteporfin Dose in Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases, 1-7.

  10. Siddique, S., & Foster, S. (2010). Central Serous Chorioretinopathy. Contemporary Ophthalmology, 1-8.

  11. Wu, Z., Lai, R., Yip, Y., Chan, W., Lam, D., & Lai, T. (2011). Improvement in Multifocal Electroretinography after Halfdose Verteporfin Photodynamic Therapy for Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 1-9.

  12. Yalcinbayir, O., Gelisken, O., Akova-Budak, V., Ozkaya, G., Cevik, S., & Yucel, A. (2014). Correlation of Spectral Domain Optical Coherence Tomography Findings and Visual Acuity in Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 705-713.




2020     |     www.medigraphic.com